The rapid growth in development of new implantable medical devices has made the need for improving the biocompatibility of implants critical. AeonClad Coating’s plasma deposition process increases biocompatibility by treating the surfaces of medical devices, stents, and catheters with ultra thin, ultra smooth coatings that better prevent protein and bacterial attachment. Our proprietary algorithm for pulsed RF plasma deposition minimizes surface bioreactivity, and thereby reduces or eliminates inflammatory responses. The coating can be tailored to eliminate cellular adhesion moieties which greatly diminishes scar tissue formation.

In addition to delivering a smooth, controlled surface, AeonClad Coatings can further increase biocompatibility, enable the reduction in inflammatory responses, and improve the wound healing process by introducing controlled release drug compounds into the coating matrix. Our flexible process also enables us to incorporate fluorophores into coatings to make implanted devices more visible to imaging systems.

Selected Publications:
Species and density of implant surface chemistry affect the extent of foreign body reactions.

Surface chemistry influences implant-mediated host tissue reponses.

Expandable bioresorbable endovascular stent. I. Fabrication and properties.